BPC-157

What is BPC-157?

BPC-157 is a synthetic 15-amino-acid peptide frequently discussed in experimental research. Interest in this compound comes mainly from laboratory and animal studies. Those findings do not establish that BPC-157 is safe or effective for treating injuries, digestive conditions, pain, or any other condition in humans.

BPC-157 5 mg product information

This page does not provide dosage, administration, diagnosis, or treatment advice.

What does the current research show?

A 2019 PubMed-indexed review examined the available literature on BPC-157 and musculoskeletal soft-tissue research. The underlying evidence discussed in that review was primarily preclinical. A later pharmacokinetic study evaluated BPC-157 in rats and dogs. Animal and laboratory findings should not be presented as proof of healing, recovery, tendon repair, or gastrointestinal benefits in people.

Regulatory context in Canada

Health Canada identifies BPC-157 among unauthorized injectable peptide drugs and warns that a “For Research Use Only” label does not remove regulatory requirements. Health Canada advises consumers to use authorized prescription drugs under the care of a licensed health professional and to look for an eight-digit Drug Identification Number (DIN).

Information for tested athletes

BPC-157 appears on the 2026 World Anti-Doping Agency Prohibited List under the non-approved substances category. Athletes subject to anti-doping rules should verify the current list and speak with their sport organization or a qualified professional.

Research context matters: evidence level, regulatory status, product identity, and independent documentation should be evaluated separately. No therapeutic benefit is claimed on this page.

Frequently Asked Questions About BPC-157

What is BPC-157?

BPC-157 is a synthetic 15-amino-acid peptide studied mainly in laboratory and animal models. It is not an established treatment for injury, pain or digestive disease.

Is there strong human clinical evidence for BPC-157?

No. The published evidence base is dominated by preclinical work. Results in cells or animals cannot establish safety, effectiveness or an appropriate medical use in people.

What does 5 mg mean on this BPC-157 vial?

It is the stated total quantity of material in the vial. It is not a dosage, frequency or administration recommendation.

Is BPC-157 authorized as a medication in Canada?

Health Canada has specifically discussed BPC-157 in its warning about unauthorized injectable peptide drugs. Researchers should consult the current Health Canada notice and applicable institutional requirements.

Does SRL provide BPC-157 dosing or reconstitution instructions?

No. This product is presented only for laboratory research and analytical testing. No dosing, reconstitution or administration instructions are provided.

Where can related peptide research be compared?

Researchers can review the TB-500 research page or browse the complete Canadian peptide research catalogue.

Research-use notice: BPC-157 5 mg is offered strictly for laboratory research. It is not intended for human consumption, self-administration, diagnosis, treatment or veterinary use.